The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
The emergence and evolution of methicillin-resistant Staphylococcus aureus
Hiramatsu, K., Cui, L., Kuroda, M., & Ito, T. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02175-8 · Cited by 825
Self-citationHolins: The Protein Clocks of Bacteriophage Infections
Wang, I.-N., Smith, D. L., & Young, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.799 · Cited by 806
Bacteriophage lysis: mechanism and regulation
Young, R. (1992) · Microbiological Reviews · doi:10.1128/mmbr.56.3.430-481.1992 · Cited by 773
A bacteriolytic agent that detects and kills Bacillus anthracis
Schuch, R., Nelson, D., & Fischetti, V. A. (2002) · Nature · doi:10.1038/nature01026 · Cited by 656
Nelson, D., Loomis, L., & Fischetti, V. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061038398 · Cited by 578
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
Loeffler, J. M., Nelson, D., & Fischetti, V. A. (2001) · Science · doi:10.1126/science.1066869 · Cited by 517
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A. N., Powell, B., Carlton, R., & Merril, C. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.204-210.2002 · Cited by 467
Leverentz, B., Conway, W. S., Camp, M. J., Janisiewicz, W. J., Abuladze, T., Yang, M., Saftner, R., & Sulakvelidze, A. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.8.4519-4526.2003 · Cited by 445
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
Tailed Bacteriophages: The Order Caudovirales
Ackermann, H.-W. (1998) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60785-x · Cited by 431
Goode, D., Allen, V. M., & Barrow, P. A. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.8.5032-5036.2003 · Cited by 383
The prospect for bacteriophage therapy in Western medicine
Merril, C. R., Scholl, D., & Adhya, S. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1111 · Cited by 367
The Control of Experimental Escherichia coli Diarrhoea in Calves by Means of Bacteriophages
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1111 · Cited by 365
Phage therapy: past history and future prospects.
Carlton, R. M. (1999) · PubMed · Cited by 342
Frequency of morphological phage descriptions in the year 2000
Ackermann, H.-W. (2001) · Archives of Virology · doi:10.1007/s007050170120 · Cited by 340
Bacteriophages show promise as antimicrobial agents
Alisky, J., Iczkowski, K., Rapoport, A., & Troitsky, N. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)92874-2 · Cited by 318
Barrow, P., Lovell, M., & Berchieri, A. (1998) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.3.294-298.1998 · Cited by 293
Linezolid resistance in clinical isolates of Staphylococcus aureus
Wilson, P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg104 · Cited by 289
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential
Barrow, P. A., & Soothill, J. S. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01054-8 · Cited by 280
Bacteriophage therapy of infectious diseases in aquaculture
Nakai, T., & Park, S. C. (2002) · Research in Microbiology · doi:10.1016/s0923-2508(01)01280-3 · Cited by 276
Vancomycin-resistant Staphylococcus aureus
Howe, R. A., Bowker, K. E., Walsh, T. R., Feest, T. G., & MacGowan, A. P. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78597-4 · Cited by 274
Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia
Loeffler, J. M., Djurkovic, S., & Fischetti, V. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6199-6204.2003 · Cited by 269
Matsuzaki, S., Yasuda, M., Nishikawa, H., Kuroda, M., Ujihara, T., Shuin, T., Shen, Y., Jin, Z., Fujimoto, S., Nasimuzzaman, M. D., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/374001 · Cited by 260
Self-citationVancomycin-resistant Staphylococcus aureus--New York, 2004.
(2004) · PubMed · Cited by 252
O’Flaherty, S., Ross, R. P., Meaney, W. J., Fitzgerald, G. F., Elbreki, M., & Coffey, A. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.4.1836-1842.2005 · Cited by 243
Atterbury, R. J., Connerton, P. L., Dodd, C. E. R., Rees, C. E. D., & Connerton, I. F. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.10.6302-6306.2003 · Cited by 235
Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., & Brüssow, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2558-2569.2004 · Cited by 234
Yoong, P., Schuch, R., Nelson, D., & Fischetti, V. A. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4808-4812.2004 · Cited by 233
Cheng, Q., Nelson, D., Zhu, S., & Fischetti, V. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.111-117.2005 · Cited by 233
Understanding Bacteriophage Therapy as a Density-dependent Kinetic Process
PAYNE, R. J. H., & JANSEN, V. A. A. (2001) · Journal of Theoretical Biology · doi:10.1006/jtbi.2000.2198 · Cited by 233
Antimicrobial drug discovery through bacteriophage genomics
Liu, J., Dehbi, M., Moeck, G., Arhin, F., Bauda, P., Bergeron, D., Callejo, M., Ferretti, V., Ha, N., Kwan, T., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt932 · Cited by 232
Kaneko, J., Kimura, T., Narita, S., Tomita, T., & Kamio, Y. (1998) · Gene · doi:10.1016/s0378-1119(98)00278-9 · Cited by 231
Overcoming the Phage Replication Threshold: a Mathematical Model with Implications for Phage Therapy
Kasman, L. M., Kasman, A., Westwater, C., Dolan, J., Schmidt, M. G., & Norris, J. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5557-5564.2002 · Cited by 221
Treatment of experimental infections of mice with bacteriophages
SOOTHILL, J. S. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-37-4-258 · Cited by 220
Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals
Payne, R. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109520 · Cited by 216
Jado, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg485 · Cited by 216
Pharmacokinetic Principles of Bacteriophage Therapy
Payne, R. J. H., & Jansen, V. A. A. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00002 · Cited by 207
Smith, H. W., Huggins, M. B., & Shaw, K. M. (1987) · Microbiology · doi:10.1099/00221287-133-5-1127 · Cited by 202
Bacteriophage Therapy of Bacterial Infections: An Update of our Institute’s Experience
Weber-Dąbrowska, B., Mulczyk, M., & Górski, A. (2001) · Inflammation · doi:10.1007/978-94-015-9702-9_15 · Cited by 199
Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail
Nakai, T., Sugimoto, R., Park, K., Matsuoka, S., Mori, K., Nishioka, T., & Maruyama, K. (1999) · Diseases of Aquatic Organisms · doi:10.3354/dao037033 · Cited by 198
Linezolid Resistance inStaphylococcus aureus:Characterization and Stability of Resistant Phenotype
Pillai, S. K., Sakoulas, G., Wennersten, C. B., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/345368 · Cited by 193
Fate of Bacteriophage Lambda in Non-immune Germ-free Mice
GEIER, M. R., TRIGG, M. E., & MERRIL, C. R. (1973) · Nature · doi:10.1038/246221a0 · Cited by 191
Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage
Hagens, S., Habel, A., von Ahsen, U., von Gabain, A., & Bläsi, U. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3817-3822.2004 · Cited by 187
Multiple Enzymatic Activities of the Murein Hydrolase from Staphylococcal Phage φ11
Navarre, W. W., Ton-That, H., Faull, K. F., & Schneewind, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15847 · Cited by 180
Experimental Bacteriophage Protection against Staphylococcus aureus Abscesses in a Rabbit Model
Wills, Q. F., Kerrigan, C., & Soothill, J. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1220-1221.2005 · Cited by 180
Phage Therapy of Local and Systemic Disease Caused by Vibrio vulnificus in Iron-Dextran-Treated Mice
Cerveny, K. E., DePaola, A., Duckworth, D. H., & Gulig, P. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6251-6262.2002 · Cited by 179
Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle
Jepson, C. D., & March, J. B. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.065 · Cited by 167
Bacteriophage control of Pseudomonas plecoglossicida infection in ayu, Plectoglossis altivelis
Park, S., & Nakai, T. (2003) · Diseases of Aquatic Organisms · doi:10.3354/dao053033 · Cited by 167
Toro, H., Price, S. B., McKee, S., Hoerr, F. J., Krehling, J., Perdue, M., & Bauermeister, L. (2005) · Avian Diseases · doi:10.1637/7286-100404r · Cited by 166
Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa
Soothill, J. S. (1994) · Burns · doi:10.1016/0305-4179(94)90184-8 · Cited by 145
Isolation and Characterization of Campylobacter Bacteriophages from Retail Poultry
Atterbury, R. J., Connerton, P. L., Dodd, C. E. R., Rees, C. E. D., & Connerton, I. F. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.8.4511-4518.2003 · Cited by 145
Loeffler, J. M., & Fischetti, V. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.375-377.2003 · Cited by 143
A Protein Antibiotic in the Phage Qβ Virion: Diversity in Lysis Targets
Bernhardt, T. G., Wang, I., Struck, D. K., & Young, R. (2001) · Science · doi:10.1126/science.1058289 · Cited by 142
Genetic evidence that the bacteriophage φX174 lysis protein inhibits cell wall synthesis
Bernhardt, T. G., Roof, W. D., & Young, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4297 · Cited by 138
Félix d`Herelle and the Origins of Molecular Biology
Summers, W. C. (1999) · Cited by 138
Mitchell, M. S., Matsuzaki, S., Imai, S., & Rao, V. B. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf524 · Cited by 136
Self-citationPhage therapy—advantages over antibiotics?
Pirisi, A. (2000) · The Lancet · doi:10.1016/s0140-6736(05)74059-9 · Cited by 130
Bernhardt, T. G., Struck, D. K., & Young, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007638200 · Cited by 125
Brahams, D. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92844-7 · Cited by 97
Bacterial viruses as human vaccines?
Clark, J. R., & March, J. B. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.4.463 · Cited by 89
Kaneko, J., Kimura, T., Kawakami, Y., Tomita, N., & Kamio, Y. (1997) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.61.1960 · Cited by 88
Genetic immunisation against hepatitis B using whole bacteriophage λ particles
March, J. B., Clark, J. R., & Jepson, C. D. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.10.047 · Cited by 87
Bacteriophage Therapy for Bacterial Infections: Rekindling a Memory from the Pre-Antibiotics Era
Ho, K. J. (2001) · Perspectives in biology and medicine · doi:10.1353/pbm.2001.0006 · Cited by 83
Inoue, T., Matsuzaki, S., & Tanaka, S. (1995) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1995.tb07342.x · Cited by 58
Self-citationDrexler, K., Dannull, J., HINDENNACH, I., Mutschler, B., & Henning, U. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90662-p · Cited by 51
Ross, J. E., Anderegg, T. R., Sader, H. S., Fritsche, T. R., & Jones, R. N. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.12.013 · Cited by 46
IKEMOTO, H., Arakawa, M., Gejyo, F., Igarashi, K., Mori, T., Okada, M., Ozaki, K., Igari, J., Aoki, N., Oguri, T., et al. (2000) · PubMed · Cited by 34
Phage offer a real alternative
Schoolnik, G. K., Summers, W. C., & Watson, J. D. (2004) · Nature Biotechnology · doi:10.1038/nbt0504-505 · Cited by 27
Dixon, B. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00951-x · Cited by 23
Matsuzaki, S., Inoue, T., & Tanaka, S. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90607-p · Cited by 13
Self-citation
Cited by
Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease
Archer, N. K., Mazaitis, M. J., Costerton, J. W., Leid, J. G., Powers, M. E., & Shirtliff, M. E. (2011) · Virulence · doi:10.4161/viru.2.5.17724 · Cited by 1,018
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Antibiotic‐Free Antibacterial Strategies Enabled by Nanomaterials: Progress and Perspectives
Wang, Y., Yang, Y., Shi, Y., Song, H., & Yu, C. (2020) · Advanced Materials · doi:10.1002/adma.201904106 · Cited by 700
Bacteriophage therapy: a potential solution for the antibiotic resistance crisis
Golkar, Z., Bagasra, O., & Pace, D. G. (2014) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.3573 · Cited by 593
Bacteriophage-encoded depolymerases: their diversity and biotechnological applications
Pires, D. P., Oliveira, H., Melo, L. D. R., Sillankorva, S., & Azeredo, J. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7247-0 · Cited by 517
Metadata
- Authors
- Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Imai, S., Ikeuchi, M., Tani, T., Fujieda, M., & Wakiguchi, H.
- Venue
- Journal of Infection and Chemotherapy
- Publisher
- Elsevier BV
- Published
- 2005
- Volume
- 11
- Issue
- 5
- Pages
- 211-219
- ISSN
- 1341-321X (ISSN-L)
- OpenAlex
- W2039853978
- Cited by
- 409
- References
- 76
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.